Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.
Oreja-Guevara C, Meca-Lallana JE, Díaz-Díaz J, Ara JR, Hernández Pérez MÁ, Gracia Gil J, Alonso Torres AM, Pilo de la Fuente B, Ramió-Torrentà L, Eichau Madueño S, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Aguado Valcárcel M, Martínez Ginés ML, El Berdei Montero Y, López Real AM, González-Quintanilla V, De Torres L, Martínez-Rodríguez JE, Costa-Frossard L, Garcés Redondo M, Labiano Fontcuberta A, Castellanos-Pinedo F, García Merino JA, Muñoz Fernández C, Castillo-Triviño T, Meca-Lallana V, Peña Martínez J, Rodríguez-Antigüedad A, Prieto González JM, Agüera Morales E, Pérez Molina I, Solar Sánchez DM, Herrera Varo N, Romero Sevilla R, Gómez Vicente L, Río J. Oreja-Guevara C, et al. Among authors: aguado valcarcel m. Mult Scler Relat Disord. 2024 Oct;90:105787. doi: 10.1016/j.msard.2024.105787. Epub 2024 Aug 2. Mult Scler Relat Disord. 2024. PMID: 39142050 Free article.
Preferences for neuromyelitis optica spectrum disorder treatments: A conjoint analysis with neurologists in Spain.
Téllez-Lara N, Gómez-Ballesteros R, Sepúlveda M, Orviz A, Díaz-Sánchez M, Boyero S, Aguado-Valcarcel M, Cobo-Calvo Á, López-Laiz P, Rebollo P, Maurino J. Téllez-Lara N, et al. Among authors: aguado valcarcel m. Mult Scler Relat Disord. 2024 Aug;88:105732. doi: 10.1016/j.msard.2024.105732. Epub 2024 Jun 17. Mult Scler Relat Disord. 2024. PMID: 38936324 Free article.
Therapeutic inertia in the management of neuromyelitis optica spectrum disorder.
Cobo-Calvo Á, Gómez-Ballesteros R, Orviz A, Díaz Sánchez M, Boyero S, Aguado-Valcarcel M, Sepúlveda M, Rebollo P, López-Laiz P, Maurino J, Téllez Lara N. Cobo-Calvo Á, et al. Among authors: aguado valcarcel m. Front Neurol. 2024 Feb 21;15:1341473. doi: 10.3389/fneur.2024.1341473. eCollection 2024. Front Neurol. 2024. PMID: 38450077 Free PMC article.
Real-world persistence to first-line DMTs in relapsing-remitting multiple sclerosis.
López-Caneda C, Pérez-Haro MJ, Sánchez-Franco C, Álvarez-Rodríguez E, Aguado-Valcárcel M, Marcos-Bobillo M, González-Suarez I. López-Caneda C, et al. Among authors: aguado valcarcel m. Mult Scler Relat Disord. 2023 Oct;78:104909. doi: 10.1016/j.msard.2023.104909. Epub 2023 Jul 22. Mult Scler Relat Disord. 2023. PMID: 37603928
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia].
Pato-Pato A, Midaglia L, Costa-Arpin E, Rodriguez-Regal A, Puy-Nunez A, Rodriguez-Rodriguez M, Lopez-Real A, Llaneza-Gonzalez MA, Garcia-Estevez DA, Moreno-Carretero MJ, Escriche-Jaime D, Aguado-Valcarcel ML, Munoz D, Prieto JM, Lorenzo-Gonzalez JR, Amigo-Jorrin MC. Pato-Pato A, et al. Among authors: aguado valcarcel ml. Rev Neurol. 2016 Sep 5;63(s01):S13-S18. Rev Neurol. 2016. PMID: 27658431 Spanish.